Abuse resistant forms of extended release morphine, method of use and method of making

Autodestructive transdermal therapeutic system

Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications

CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE

Sigma ligands for neuronal regeneration and functional recovery

Abuse resistant forms of extended release morphine with oxycodone, method of use and method of making

Abuse resistant forms of extended release hydrocodone, method of use and method of making

Abuse resistant forms of extended release oxymorphone, method of use and method of making

Abuse resistant forms of extended release oxycodone, method of use, and method of making

Abuse resistant forms of extended release hydromorphone, method of use and method of making

Transdermal patch with fatal overdose protection

METHODS FOR TREATING VISCERAL FAT CONDITIONS

IBUPROFEN AND NARCOTIC ANALGESIC COMPOSITIONS

Tamper-resistant pharmaceutical compositions of opioids and other drugs

Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease

Morphinan derivatives for the treatment of drug overdose

(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof

ABUSE-RESISTANT OPIOID DOSAGE FORM

THERAPY FOR VITILIGO

Morphine and morphine precursors

Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture

CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE

DISSOLVABLE PHARMACEUTICAL IMPLANT

8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

Intranasal opioid compositions

Method of restoring the incretin effect

6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands

Opioid-ketamine and norketamine codrug combinations for pain management

Opioid-nornicotine codrugs combinations for pain management

1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof

Sublingual apomorphine

Analgesics for nasal administration

Inhibitor of analgesic tolerance

Transdermal therapeutic buprenorphine system

ONCE-A-DAY OXYCODONE FORMULATIONS

Tamper-resistant oral opioid agonist formulations

Oral Pharmaceutical Compositions of Buprenorphine and Method of Use

Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting

Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

Topical compositions of opioid antagonists and methods for treating skin conditions therewith

Methods and compositions for deterring abuse

Sustained-Release Opiate and Opiate Derivative Compositions

Abuse resistant drugs, method of use and method of making

Method Of Inhibiting Mucin Secretion

Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high pH environments

Medication Combinations for the Treatment of Alcoholism and Drug Addiction

Pharmaceutical compositions for treatment of addiction

Formoterol superfine formulation

Methods for administering weight loss medications

Spirocyclic cyclohexane compounds useful to treat substance dependency

SUSTAINED RELEASE OF GUAIFENESIN

COMBINATION ANALGESIC OPIOID PAIN THERAPY

Medicinal Compositions

MODULATION OF NEUROGENESIS WITH GABA AGENTS AND GABA ANALOGS

Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy

NOVEL PHARMACEUTICAL COMPOSITIONS FOR OPTIMIZING SUBSTITUTION TREATMENTS AND EXTENDING THE PHARMACOPOEIA TO GLOBAL TREATMENT OF ADDICTIONS

Prolonged release bioadhesive therapeutic systems

Controlled release hydrocodone formulations

Method of restoring the incretin effect

SUBLINGUAL AND BUCCAL FILM COMPOSITIONS

Sublingual and buccal film compositions

COMPOSITIONS AND METHODS FOR REDUCING FOOD CRAVINGS

Low viscosity liquid polymeric delivery system

Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same

Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same

Self-destructing transdermal therapeutic system having improved functionality and efficacy

Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Depression, Anxiety, and Neurodegenerative Disorders

Treatment with opioid antagonists and mTOR inhibitors

Method for reducing pain with ziconotide and baclofen

Method for reducing pain with ziconotide and morphine

Methods for treatment of pain

TAMPER-RESISTANT DOSAGE FORM FOR OXIDATION-SENSITIVE OPIOIDS

Titratable dosage transdermal delivery system

ABUSE-RESISTANT OPIOID DOSAGE FORM

STABLE SOLUTIONS OF SPARINGLY SOLUBLE ACTIVES

(+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof

Use of analgesic potentiating compounds to potentiate the analgesic properties of an analgesic compound

THERAPEUTIC TABLET FOR POSTHERPETIC NEURALGIA AND METHOD OF TREATING POSTHERPETIC NEURALGIA

Sustained release solid formulations and methods of manufacturing the same

Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics

Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof

Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof

Abuse resistant oral opioid formulations

PREOPERATIVE TREATMENT OF POST OPERATIVE PAIN

Intranasal Opioid Compositions

Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs

Medicament for prophylaxis and treatment of Alzheimer disease

Synthesis of -methylnaltrexone

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

Noribogaine in the treatment of pain and drug addiction

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

NORIBOGAINE IN THE TREATMENT OF PAIN AND DRUG ADDICTION

Method and composition for potentiating an opiate analgesic

Therapeutic approaches for treating CMT and related disorders

Compositions and methods for treating pruritus

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

CRYSTAL FORMS OF (R)-N-METHYLNALTREXONE BROMIDE AND USES THEREOF

POLYMERIC DRUG DELIVERY SYSTEMS AND THERMOPLASTIC EXTRUSION PROCESSES FOR PRODUCING SUCH SYSTEMS

Aerosol generating method and device

Pack of medicinal tablets

Antibiotic formulation and method of treatment

ORGANIC COMPOUNDS

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MITIGATING RISK OF ALCOHOL INDUCED DOSE DUMPING OR DRUG ABUSE

Opioid agonist/antagonist combinations

Drug-Loaded Fibers

COMPOSITIONS FOR TREATING PARKINSON'S DISEASE

NOVEL DICARBOXYLIC ACID LINKED AMINO ACID AND PEPTIDE PRODRUGS OF OPIOIDS AND USES THEREOF

Use of opioid antagonists

ANTIBIOTIC/BONE MORPHOGENIC PROTEIN FORMULATION AND METHOD OF TREATMENT

COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS

COMPOSITIONS COMPRISING AN ANTIHISTAMINE, ANTITUSSIVE AND DECONGESTANT IN EXTENDED RELEASE FORMULATIONS

Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins

Methods and compositions for treating dry eye

PHARMACEUTICAL FORMULATION

Pharmaceutical Suspensions and Related Methods

PHARMACEUTICAL COMPOSITIONS

PROSTATIC ACID PHOSPHATASE FOR THE TREATMENT OF PAIN

PHARMACEUTICAL FORMULATION

PHARMACEUTICAL FORMULATION

Stable methylnaltrexone preparation

Pharmaceutical formulation containing irritant

Abuse-deterrent drug formulations

ABUSE-PROOFED DOSAGE FORM

External preparation composition comprising fatty acid-based ionic liquid as active ingredient

Compounds that inhibit (block) bitter taste in composition and use thereof

Electrical stimulation of iliohypogastric nerve to alleviate chronic pelvic pain

FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF

SUSTAINED RELEASE TABLETS WITH HYDROMORPHONE

Nanoparticulate and controlled release compositions comprising nilvadipine

MORPHINAN DERIVATIVES WITH HIGH ORAL BIOAVAILABILITY

Controlled release pharmaceutical compositions for prolonged effect

Misuse preventative, controlled release formulation

DRUG DEPOTS FOR TREATMENT OF PAIN AND INFLAMMATION IN SINUS AND NASAL CAVITIES OR CARDIAC TISSUE

TLR MODULATORS AND METHODS FOR USING THE SAME

Novel Neurological Function of mPKCI

Administration of intravenous ibuprofen

COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND TREATMENT OF ADDICTIONS

Method of Treating Pain by Using Opioids and CAMKIV Inhibitors

Methods of Reducing Side Effects of Analgesics

Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts

Abuse-Resistant Pharmaceutical Dosage Form

CONTROLLED RELEASE FORMULATIONS OF OPIOID AND NONOPIOID ANALGESICS

Oral composition comprising a cooling agent

Extended release opioid abuse deterrent compositions and methods of making same

MODULATION OF NEUROGENESIS BY NOOTROPIC AGENTS

Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation

Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

Chemically modified small molecules

METHODS AND APPARATUS FOR THE ENHANCED DELIVERY OF PHYSIOLOGIC AGENTS TO TISSUE SURFACES

Neurotensin receptor agonists and opioid receptor agonists

ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS COMPRISING DOMPERIDONE AND METHODS OF USING SAME

Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level

Alkaloid formulations

Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level

Immediate release composition resistant to abuse by intake of alcohol

Pharmaceutical compositions resistant to abuse

CONTROLLED RELEASE FORMULATIONS WITH CONTINUOUS EFFICACY

COMBINATION OF A 5HT7 RECEPTOR LIGAND AND AN OPIOID RECEPTOR LIGAND

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

OROS PUSH-STICK FOR CONTROLLED DELIVERY OF ACTIVE AGENTS

COMPOSITIONS FOR AFFECTING WEIGHT LOSS

OPIOID DELIVERY SYSTEM

CONTROLLED RELEASE SYSTEMS FROM POLYMER BLENDS

Treatment of dyskinesia

PROCESS FOR PREPARING PARTICLES OF OPIOIDS AND COMPOSITIONS PRODUCED THEREBY

Preparation for transnasal application

Non-mucoadhesive film dosage forms

ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION

Pharmaceutical composition

Pharmaceutical formulation containing gelling agent

Medicinal Compositions Comprising Buprenorphine And Naloxone

COMPOSITIONS AND METHODS FOR MINIMIZING OR REDUCING AGONIST-INDUCED DESENSITIZATION

Modified release formulations containing drug-ion exchange resin complexes

Crystalline micropowder particles

EXTENDED-RELEASE PHARMACEUTICAL FORMULATIONS

Dendrimer conjugates

TREATMENT OF RESTLESS LEG SYNDROME AND SLEEP DISORDERS

8a,14-dihydroxy-7,8-dihydrocodeinone

Functionalized drugs and polymers derived therefrom

Methods for Enhancing Stability of Polyorthoesters and Their Formulations

Medicinal compositions comprising buprenorphine and nalmefene

Pharmaceutical composition

CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS

Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment

Method for producing pharmaceutical tablet

PHARMACEUTICAL COMPOSITION

Film preparation with rapidly dissolving property and flexibility

Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines

Methods and compositions for treating or preventing narcotic withdrawal symptoms

COMPOSITIONS AND METHODS FOR ENHANCING ANALGESIC POTENCY OF COVALENTLY BOUND-COMPOUNDS, ATTENUATING ITS ADVERSE SIDE EFFECTS, AND PREVENTING THEIR ABUSE

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist

Pharmaceutical compositions

ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

Liquid therapeutic composition

Therapeutic or prophylactic agent for dyskinesia

Non-abusable pharmaceutical composition comprising opioids

Stable solid preparation containing 4,5-epoxymorphinan derivative

Peripheral opioid receptor antagonists and uses thereof

Medicinal compositions comprising buprenorphine and naltrexone

LONG-ACTING INJECTABLE ANALGESIC FORMULATIONS FOR ANIMALS

Transdermal therapeutic system for administering the active substance buprenorphine

Method for Treating Pain with a Calmodulin Inhibitor

PHARMACEUTICAL COMPOSITIONS COMPRISING AN OPIOID RECEPTOR ANTAGONIST AND METHODS OF USING SAME

INDOLONE MODULATORS OF 5-HT3 RECEPTOR

Method and composition for potentiating an opiate analgesic

Transdermal therapeutic system comprising ion pair microreservoirs

Penis Enlargement

Method for treating withdrawal symptoms due to opiate consumption

EXTENDED RELEASE ORAL ACETAMINOPHEN/TRAMADOL DOSAGE FORM

Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders

Abuse-resistant oral dosage forms and method of use thereof

PROCESS FOR PRODUCTION OF BUPRENORPHINE PHARMACEUTICAL PREPARATION TO BE APPLIED TO MOUTH MUCOSA

Sustained release parenteral formulations of buprenorphine

Two-component pharmaceutical composition for the treatment of pain

CONTROLLED RELEASE OXYCODONE COMPOSITIONS

Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic

Anti-misuse microparticulate oral pharmaceutical form

USE OF METHYLNALTREXONE AND RELATED COMPOUND TO TREAT CONSTIPATION IN CHRONIC OPIOID USERS

Buprenorphine-wafer for drug substitution therapy

COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH CERAMIDE BIOSYNTHESIS

MILNACIPRAN FOR THE TREATMENT OF FATIGUE ASSOCIATED WITH FIBROMYALGIA SYNDROME

Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same

ABUSE-RESISTANT TRANSDERMAL DOSAGE FORM

Use of tellurium containing compounds as nerve protecting agents

SYNERGISTIC EFFECTS OF COMBINATIONS OF NORNICOTINE AND OPIOIDS FOR THE TREATMENT OF PAIN

Oligomer-opioid agonist conjugates

Method and dosage regimens for eliminating a chemical substance in blood

Pharmaceutical spheroids

Combined Effects of Topiramate and Ondansetron on Alcohol Consumption

Buprenorphine formulations for intranasal delivery

Method for Improving Uniformity of Content in Edible Film Manufacturing

Compositions for Reducing Nicotine Withdrawal Symptoms and/or Tobacco Usage

Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases

8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

Process for the preparation of quaternary N-alkyl morphinan alkaloid salts

PARENTERAL FORMULATIONS OF DOPAMINE AGONISTS

Controlled release of phenolic opioids

NON-AQUEOUS LIQUID FORMULATION FOR NASAL OR BUCCAL ADMINISTRATION

CONTROLLED RELEASE OXYCODONE COMPOSITIONS

Non-polymeric compositions for controlled drug delivery

Methods and Compositions for Treating Migraine Pain

HYDROMORPHONE THERAPY

Methods to Treat Pain Using an Alpha-2 Adrenergic Agonist and an Endothelin Antagonist

Crush-Resistant Tablets Intended to Prevent Accidental Misuse and Unlawful Diversion

TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE

TRANSORAL DOSAGE FORMS COMPRISING SUFENTANIL AND NALOXONE

Extended release hydrocodone acetaminophen and related methods and uses thereof

Acute Pain Medications Based on Fast Acting Diclofenac-Opioid Combinations

CANCER TREATMENT METHOD

5 HT RECEPTOR MEDIATED NEUROGENESIS

Pharmaceutical compositions and methods for peptide treatment

MAPC therapeutics without adjunctive immunosuppressive treatment

AGENT FOR SUPPRESSING DEVELOPMENT OF TOLERANCE TO NARCOTIC ANALGESICS

ENTERIC COATED HYDROPHOBIC MATRIX FORMULATION

Injectable delivery of microparticles and compositions therefore

Electrical stimulation method for treatment of peripheral neuropathy

5 HT RECEPTOR MEDIATED NEUROGENESIS

USE OF OPIOID RECEPTOR ANTAGONISTS

ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION

USE OF METHYLNALTREXONE AND RELATED COMPOUNDS FOR TREATMENT OF GASTROINTESTINAL DYSFUNCTION INDUCED BY ENDOGENOUS OPIOIDS

METHOD FOR MANAGEMENT OF DIARRHEA

Combination therapy for bipolar disorder

Composition

Non-Codeine Opioid Analgesic Process And Formulations

SUSTAINED RELEASE OPIOID FORMULATIONS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION

Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition

Materials and Methods Relating to the Induction of Apoptosis in Target Cells

Abuse-deterrent pharmaceutical compositions of opioids and other drugs

Modified Release Loxoprofen Compositions

Modified Release Ticlopidine Compositions

Therapeutic Agent for Nausea and/or Vomiting

DUAL OPIOID PAIN THERAPY

Transdermal delivery of cannabidiol

Opioid Combination Wafer

CAPSULE AND COATED CAPSULES AS A DELIVERY SYSTEM FOR DIETARY SUPPLEMENTS AND THERAPEUTIC MATERIALS

VR1 Receptor Ligands and u-Opioid Receptor Ligands for the Treatment of Pain

Combinations for treating HIV-associated pain

Compounds that inhibit (block) bitter taste in composition and use thereof

Prophylactic/therapeutic agent for alzheimer's disease

Use of Buprenorphine or N-Alkylated Derivatives Thereof for Wound Healing

Kappa opioid receptor ligands

COMBINED HYDROCODONE AND ANALGESIC FORMULATION AND METHOD

ANALGESIC AND ANTI-INFLAMMATORY COMPOSITIONS AND METHODS FOR REDUCING, PREVENTING OR TREATING PAIN AND INFLAMMATION

PRESSURISED METERED DOSE INHALERS CONTAINING SOLUTIONS OF BETA-2 AGONISTS

Composition of Rapid Disintegrating Direct Compression Buccal Tablet

Drug depots having different release profiles for reducing, preventing or treating pain and inflammation

Method and composition for deterring abuse of opioid containing dosage forms

Analgesic agent

Methods and Compositions for Treating Nociceptive Pain

Pharmaceutical formulations for reducing pain

ABUSE DETERRENT TRANSDERMAL FORMULATIONS OF OPIATE AGONISTS AND AGONIST-ANTAGONISTS

Delivery of antipsychotics through an inhalation route

Sustained Release Dosage Forms of Analgesic Medications

Abuse-resistant oral dosage forms and method of use thereof

Pharmaceutical composition having reduced abuse potential

Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative